Products & Development
Research & Technology
Partnering
Investor Relations
Media Centre
Careers
Home







Upcoming Events

MethylGene Corporate Presentation
June 208
Click here to view

Publication
Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay
Clinical Cancer Research 2008;14(11) June 1, 2008

ASCO 2008 Annual Meeting
May 31 to June 3, 2008 - Chicago
Poster Trial 006  -  Poster Trial 010  -  Poster Trial 008





  Print this page
 Today is Saturday, July 05, 2008

Latest news



Investor Relations



Our Stock Symbol: MYG.TO
Last price: 1.95
Volume 2600
Open: 1.96
High: 1.96
Low: 1.95
52 Week Range: 1.82 - 4.00

info@methylgene.com Disclaimer